Objective: Myxofibrosarcoma is clinically characterized by a high frequency of local recurrence after surgery. To improve the clinical outcome of patients with myxofibrosarcoma, it is imperative to control any postsurgical local recurrence. Methods: In this study, we performed a retrospective clinicopathologic analysis of 100 consecutive patients with myxofibrosarcoma to identify factors related to poor prognosis. All of the patients had been diagnosed, and had undergone surgery at the National Cancer Center Hospital between 1999 and 2008. Results: At the initial visit to our hospital, 64 patients had primary myxofibrosarcoma, whereas 36 had undergone primary unplanned resection at other facilities. Of the 36 patients, 11 consulted our hospital before recurrence and 25 did so after recurrence. A histologically positive margin after surgery was evident in 28% of the cases overall. The estimated 5-year recurrencefree survival rate was 74.8%. Univariate analysis showed that primary unplanned resection at another facility (P ¼ 0.0001) and a histologically positive margin (P ¼ 0.0224) were significant predictors of local recurrence. When these two factors were subjected to multivariate analysis, only primary unplanned resection at another facility was significantly correlated with the estimated recurrence-free survival rate (P ¼ 0.0011). Primary unplanned resection was also significantly related to the 5-year disease-free survival rate (P ¼ 0.0401). Conclusions: Our findings indicate that primary unplanned resection at a non-referral hospital is the most important risk factor related to poor prognosis of myxofibrosarcoma. Accurate diagnosis and adequate initial surgery are most important factors for improving the clinical outcomes of myxofibrosarcoma.
INTRODUCTION
Myxofibrosarcoma (MFS) is a common type of adult soft tissue sarcoma, particularly affecting the extremities in the elderly (1) . In Japan, it is expected that the number of patients with MFS will increase further as society gradually ages (2) , and the tumor is now being recognized more frequently following the latest World Health Organization (WHO) classification (1) .
A characteristic clinical feature of MFS is its propensity for persistent local recurrence, even after wide resection (1, 3, 4) .
In previous reports, local recurrence rates have ranged from 22 to 79%, irrespective of grade, depth and size (4 -7) . In addition, 15 -38% of locally recurrent MFS cases progress to a higher grade with an attendant increase of metastatic potential (1,3,7 -9) .
Although most patients with soft tissue sarcomas can achieve local recurrence-free limb preservation after resection with an adequately wide margin (.2 cm) (10) , it remains unclear whether such wide resection for MFS is the optimal local treatment. In MFS, histologically negative margins after surgery are frequently difficult to achieve because MFS has an unusual infiltrative growth pattern, especially along the fascial planes and muscle bundles, which is often more extensive than initially suggested by magnetic resonance imaging (MRI) (1, 11, 12) . This infiltrative growth pattern of MFS can result in anatomically deceptive boundaries at surgery because of microscopic extension. However, no studies involving large series have yet investigated the factors associated with local recurrence of MFS after surgery.
In the present retrospective study, we examined a large series of 100 patients with MFS to identify the clinicopathologic factors associated with poor prognosis after surgery.
PATIENTS AND METHODS

PATIENTS
This study included a total of 100 consecutive patients with histologically proven MFS who were treated by surgery with or without adjuvant therapy at the National Cancer Center Hospital (NCCH) between 1999 and 2008. All cases were reviewed and histologically confirmed by a certified pathologist based on the WHO classification of soft tissue tumors (1) . The median follow-up period was 65 months (range 1 -198 months; mean 62.9 months). This study was approved by the ethical review board of the National Cancer Center.
Clinical data including tumor status at the initial visit, gender, age at surgery, tumor location, tumor depth, histological grade, histological margin of the surgery, adjuvant treatments, period until recurrence, period until metastasis and last follow-up were retrieved from the charts.
Tumor status at the initial visit was classified according to whether the patient received primary wide resection at the NCCH or had undergone primary unplanned resection at a non-specialized facility. The patients who had undergone primary unplanned resection at a non-specialized facility were divided into two groups: those histologically diagnosed as having MFS after surgery and who consulted our hospital immediately before recurrence, and those who consulted our hospital after recurrence without any histological diagnosis. Tumor depth was classified as either superficial MFS located in subcutaneous tissue without invasion of the muscle fascia or deep-seated MFS located in intramuscular tissues beneath the muscle fascia. Histological grade was determined on the basis of the French Federation of Cancer Centers (FNCLCC grade) grading system. This classification is based on the mitotic index, extent of necrosis and degree of histological differentiation of the tumor (13) (14) (15) .
All patients underwent MRI including gadoliniumenhanced sequences for surgical planning, and the extent of the tumor area was evaluated meticulously from gadoliniumenhanced fat-suppressed T1-weighted images. We then evaluated the surgical margin .3 cm from the distal portion of the area of tumor extension seen in the images. All patients underwent complete resection with a margin of .3 cm. Patients with primary MFS underwent primary wide resection including amputation, patients histologically diagnosed as having MFS and who consulted our hospital immediately before recurrence underwent additional wide resection and patients who consulted our hospital after recurrence without any histological diagnosis underwent wide resection for the recurrent tumor. Histological margins were evaluated after surgery in all patients. Decisions on whether to administer radiotherapy and/or chemotherapy were made at multidisciplinary sarcoma group meetings. After the meetings, we provided objective data on the risks and benefits related to adjuvant therapies to the patients and conducted therapies only for patients who provided informed consent. For patients considered to have a higher-than-average risk of recurrence on the basis of clinical findings such as anatomical location and an inadequate margin expected on the basis of surgical planning, external beam radiation at doses ranging from 30 to 60 Gy or brachytherapy at a dose of 36 Gy was administered. Systemic chemotherapy was administered at the discretion of the multidisciplinary sarcoma group and based on whether the patient had provided informed consent. Anthracycline-based regimens were used in most patients. The characteristics of the 100 patients are summarized in Table 1 .
STATISTICAL ANALYSIS
Tumor recurrence after surgery at the NCCH was used as the end point, and calculated from the date of surgery. The recurrence-free survival rate was estimated using the KaplanMeier method (16) . Relationships between the recurrence-free survival rate and other variables were investigated using the log-rank test for categorical variables and a score test based on the Cox proportional hazards model for continuous variables. Differences at P , 0.05 were considered to be statistically significant. Multivariate analysis using Cox regression was carried out on variables shown to be significant at the univariate level (17) (P , 0.05). Statistical computations were done using the Stat-View version 5.0 statistical software package (SAS Institute). The disease-free survival rate was also estimated using the Kaplan -Meier method (16) . Primary tumor events including tumor recurrence, metastasis or death due to disease after surgery at the NCCH were used as the end point, and were calculated from the date of surgery. Differences at P , 0.05 were considered to be statistically significant.
RESULTS
The average age of the 100 patients at surgery was 64 years (range 23 -97 years), and there was a male predominance (61 males and 39 females). According to the tumor status at the initial visit, 64 patients had treated primary tumors and 36 had received primary unplanned resection at a non-specialized hospital. Seventy-seven tumors were located in the extremities, including 28 in the upper limbs, 49 in the lower limbs and 23 in the trunk including two in the neck region. Figure 1 shows the local recurrence-free survival curves for the 100 patients as a whole. The 5-year local recurrence-free survival rate was 74.8%.
When the patients were stratified according to the status at the initial visit, the estimated 5-year recurrence-free survival rate was 89.0% for those with primary tumors and 55.0% for those who had undergone initial unplanned surgery at the previous non-specialized hospital (P ¼ 0.0001, Fig. 2A ). We further investigated whether the difference in local tumor status after unplanned primary resection was significantly correlated with the 5-year recurrence-free survival rate. Of the 36 patients with primary unplanned resection, 11 underwent additional wide resection before recurrence, and 25 underwent wide resection after recurrence. The estimated 5-year recurrence-free survival rate was 43.6% for those with additional wide resection and 61.2% for those with wide resection for recurrence. The difference in local tumor status after primary unplanned resection did not significantly correlate with the 5-year recurrence-free survival rate (P ¼ 0.6303).
There were also significant differences in the estimated 5-year recurrence-free survival rates between patients with a histologically positive margin (61.5%) and those with a histologically negative margin (79.8%) (P ¼ 0.0224, Fig. 2B) .
No other factors examined, including age at surgery, gender, tumor depth, tumor location, adjuvant therapy and FNCLCC grade, were associated with an increased risk of local recurrence (Table 2 ). Multivariate analysis revealed that primary unplanned resection at a previous non-specialized hospital was the only factor significantly correlated with the 
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Recurrence related factors of MFS estimated recurrence-free survival rate (P ¼ 0.0011, relative risk 5.35, 95% confidence interval 0.068 -0.513; Table 2 ). We further investigated whether primary unplanned resection, identified as a significant predictor of recurrence by univariate and multivariate analyses, was significantly correlated with the estimated disease-free survival rate. From the 100 patients included in this study, 50 remained continuously disease-free (CDF), 35 showed no evidence of disease (NED), 9 were alive with disease (AWD) and 6 died of disease (DOD) ( Table 1) . Eleven patients had metastases after surgery (10 in the lung and one in the lymph nodes, Table 1 ). The estimated 5-year disease-free survival rate for the 100 patients was 63.9% (Fig. 3A) . Primary unplanned resection was significantly related to the 5-year disease-free survival rate (P ¼ 0.0401, Fig. 3B ). Meanwhile, primary unplanned resection was not significantly associated with overall survival. DOD occurred in only six patients during the follow-up period. Remarkably, two of those six patients died because of local failure after surgery despite the absence of metastases. Of these two patients, one died because of uncontrollable local recurrence after surgery (Case 6, Table 1 ), and the other died due to local infection after surgery without any disease recurrence (Case 39, Table 1 ).
DISCUSSION
MFS is clinically characterized by a high frequency of local recurrence after surgery because of its potential for unusual infiltrative growth (11, 12) . Previous reports have documented local repeated recurrences after surgery in up to 50 -60% of cases (3, 6, 7) . In the present study, primary unplanned resection at another facility and a histologically positive margin after surgery were factors significantly related to poor prognosis of MFS. At present, the only established radical treatment for MFS is primary wide resection with a histologically negative margin. The rate of local recurrence is strongly affected by the quality of primary surgery. Merk et al. (7) reported that the local failure rate for primary wide resections was 17%, in comparison with 79% for non-wide resections. Therefore, primary wide resection with an accurately assessed surgical margin is most important for local control of MFS.
Thirty-six of the present cases were treated by primary unplanned resection at a non-specialized facility without any doubt as to the diagnosis. One of the reasons for these inadequate resections may have been that about two-thirds of MFS cases develop in subcutaneous tissue. In fact, 30 (83.3%) of the 36 cases treated at a non-specialized facility were located in subcutaneous tissue, as were 34 (53.1%) of the 64 cases treated primarily at the NCCH. Another reason for inadequate surgery was that the MFS tumors were comparatively small and asymptomatic initially. The tumor diameter was ,5 cm in 16 of the 64 cases (25%) in our series.
Our present findings indicate that MFS should be consistently considered in the differential diagnosis of soft tissue tumors located in subcutaneous tissue. Huang et al. (4) indicated that MFS is prone to misinterpretation as benign or malignant myxoid mimickers such as myxoid liposarcoma, low-grade fibromyxoid sarcoma, cellular myxoma and nodular fasciitis. A significant feature to consider in the differential diagnosis of MFS is the presence of an infiltrative growth pattern on MRI. It has been reported that such an infiltrative growth pattern is especially obvious in gadoliniumenhanced fat-suppressed T1-weighted images (12, 18) . Accordingly, a careful evaluation using MRI imaging should be performed before primary surgery.
Malignant bone and soft tissue sarcomas are rare, accounting for ,1% of all tumors (19, 20) , and orthopedic surgeons who are not specialized in musculoskeletal tumors encounter, on average, less than one patient with a tumor of the musculoskeletal system every 3 years (20, 21) . Therefore, nonspecialized clinicians generally cannot be expected to possess basic knowledge of the diagnostic and therapeutic principles for MFS (21) . In a study of 1460 musculoskeletal tumors, Grimer concluded that those exceeding golf ball (4.27 cm) size had a potential for malignancy (22) . His study serves as an example that effective education about MFS is important for avoiding primary unplanned resection of this tumor.
In MFS patients who undergo primary unplanned resection and are thus at high risk of local recurrence, it is thought necessary to consider additional resections. Merk et al. (7) Figure 2. Kaplan -Meier estimated recurrence-free survival curves based on (A) tumor status at initial visit and (B) histological margin. Primary unplanned resection at a non-specialized facility (P ¼ 0.0001, log-rank test) and a histologically positive margin (P ¼ 0.0224, log-rank test) were significant predictors of local recurrence.
reported that if non-radical excisions preceded a radical resection, the local failure rate was up to 33%, in comparison to 17% for primary wide resection because of the unusual infiltrative growth of MFS. It is known that MFS is often more extensive than initially suggested by MRI (18) . Primary non-wide resection leads to dissemination of tumor cells via hemorrhage and edema beyond the primary site of the tumor. Such hemorrhage and edema after surgery make it more difficult to identify the total extent of the tumor by MRI. These clinical conditions explain the high rate of local recurrence after additional wide resection. Our findings also indicated a higher rate of local recurrence after additional wide resection (54.5%; 6 of 11 cases) than after primary wide resection (7.8%; 5 of 63 cases). As was the case for additional wide resection, patients who underwent wide resection for recurrent tumors had a high recurrence rate after surgery, presumably for similar reasons. Furthermore, Waters et al. reported that recurrent MFS had a particular propensity for infiltrative growth and poorly defined margins on MRI because it did not show an apparent pseudocapsule in the images, unlike other types of soft tissue sarcomas. Given this infiltrative tendency of recurrent MFS, the full extent of the tumor is difficult to determine or may be overlooked. If the radiologic description of the tumor is limited to its extent, and surgery is planned on that basis, then the resection margins may be inadequate and recurrence imminent (11) . These findings highlight the clinical features of MFS that make it different from other types of soft tissue sarcomas, and also indicate the importance of There were no recurrent cases in Grade 1. We analyzed the prognositc value between G2 and G3 for 5-year recurrence-free survival rate.
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Recurrence related factors of MFS primary planned resection with an accurately assessed surgical margin for local control. In MFS patients who are at a high risk of local recurrence after surgery, it is necessary to consider additional therapeutic approaches such as radiotherapy or chemotherapy. The impact of radiotherapy in an adjuvant setting on relapse-free survival of MFS patients remains to be proven (23, 24) . In a previous series reported by Karl et al., radiotherapy was given to 28 MFS patients pre-and/or postoperatively, and 11 of them later developed local recurrence, suggesting that radiotherapy had no significant impact (23) . Sanfilippo et al. (24) also reported that radiotherapy had apparently only limited value for reducing the risk of local recurrence, although the patients in their series who received radiotherapy already had unfavorable prognostic factors such as a large tumor size, deep location, and high histological grade. In addition, the role of adjuvant chemotherapy in the treatment of soft tissue sarcoma is still debatable (25, 26) . Also in our present study, radiotherapy (which was used in 16 cases) seemed to be only of limited value for reducing the risk of local recurrence, and adjuvant chemotherapy (which was used in 9 of these patients) proved not to be an independent prognostic factor. Therefore, primary wide resection for MFS is considered to be the only reliable treatment that can offer local tumor control.
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